Clinical Trials Directory

Trials / Unknown

UnknownNCT04577560

Telomere Length in Human Polar Body and Telomere Length in Cumulus Cells: A Clinical Validation Study

Does the Telomere Length in First Human Polar Body Correlates With the Telomere Length in Cumulus Cells: A Clinical Validation Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
ART Fertility Clinics LLC · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Accepted

Summary

To investigate whether telomere length (TL) of the first Polar body (PB) correlates with TL in Cumulus cells (CC)

Detailed description

With the present study we want to analyze, as a primary objective, whether telomere length (TL) in the first Polar Body (PB) correlates with TL in the corresponding Cumulus cells (CC). As a secondary objective, a possible correlation between TL in PBs and blastocyst TL and ploidy will be evaluated. To our best knowledge, there are no studies evaluating TL in CC and TL in PBs of the corresponding oocyte. With the present prospective study, we sought to investigate whether there is a correlation between CC-TL and PB-TL. If a correlation exists, CC-TL assessment would serve as a valuable non-invasive technique to gain information about oocyte competence.

Conditions

Interventions

TypeNameDescription
GENETICFirst polar body biopsy in MII oocytesSince PBs are by-products of the meiotic division of the oocyte and are not required for fertilization and subsequent embryo development, they can be removed to assess exclusively maternal chromosomal information without harming the embryo integrity. As previously described, PB biopsy does not impact the morphokinetic parameters of the embryo development and can be safely applied without the risk of impairing the reproductive potential of the embryo.
GENETICPGT-A blastocystpreimplantation genetic screening for aneuploidies

Timeline

Start date
2021-06-06
Primary completion
2021-12-01
Completion
2022-01-01
First posted
2020-10-08
Last updated
2021-06-09

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT04577560. Inclusion in this directory is not an endorsement.